Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems

Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1981-11, Vol.24 (11), p.1284-1287
Hauptverfasser: Rogers, Michael E, Glennon, Richard A, Smith, J. Doyle, Boots, Marvin R, Nanavati, Nitin, Maconaughey, Julie E, Aub, Debbie, Thomas, Sheree, Bass, R. G, Mbagwu, Godwin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1287
container_issue 11
container_start_page 1284
container_title Journal of medicinal chemistry
container_volume 24
creator Rogers, Michael E
Glennon, Richard A
Smith, J. Doyle
Boots, Marvin R
Nanavati, Nitin
Maconaughey, Julie E
Aub, Debbie
Thomas, Sheree
Bass, R. G
Mbagwu, Godwin
description Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.
doi_str_mv 10.1021/jm00143a004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73756986</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73756986</sourcerecordid><originalsourceid>FETCH-LOGICAL-a294t-2cc8e03d9d65eb8d4a1c4ff3b51fd8f853cc1437431f023e502baef72f3edb433</originalsourceid><addsrcrecordid>eNptkMtrGzEQxkVJSdykp54DOiWHsu3osQ_3FkJexW4Mds9Cq5USuburjcYb6v8-Mjahhx6Ggfl-fDPzEfKFwTcGnH1fdwBMCg0gP5AJyzlksgJ5RCYAnGe84OKEfEJcA4BgXByT44KXIs-rCWnnFoMPvTd0GKPvQ2-p7nUbnpBqpL5_9rXfhIg0OGq2pvUmu5ov6PAcMFXjLW5s1Gh_UBO6QUePod-xaF_TvKXJ84niNlEdnpGPTrdoPx_6Kfl9e7O6vs9mj3cP11ezTPOp3GTcmMqCaKZNkdu6aqRmRjon6py5pnJVLoxJ_5ZSMAdc2Bx4ra0ruRO2qaUQp-Ri7zvE8DKmC1Xn0di21b0NI6pSlHkxrYoEft2DJgbEaJ0aou903CoGapet-ifbRJ8fbMe6s807ewgz6dle9-nbv--yjn9UsVupVoul4nfL1c_7XzM1T_zlntcG1TqMMeWO_938BijwkkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73756986</pqid></control><display><type>article</type><title>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Rogers, Michael E ; Glennon, Richard A ; Smith, J. Doyle ; Boots, Marvin R ; Nanavati, Nitin ; Maconaughey, Julie E ; Aub, Debbie ; Thomas, Sheree ; Bass, R. G ; Mbagwu, Godwin</creator><creatorcontrib>Rogers, Michael E ; Glennon, Richard A ; Smith, J. Doyle ; Boots, Marvin R ; Nanavati, Nitin ; Maconaughey, Julie E ; Aub, Debbie ; Thomas, Sheree ; Bass, R. G ; Mbagwu, Godwin</creatorcontrib><description>Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00143a004</identifier><identifier>PMID: 6273558</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - antagonists &amp; inhibitors ; Chemical Phenomena ; Chemistry ; Purinones - chemical synthesis ; Purinones - pharmacology</subject><ispartof>Journal of medicinal chemistry, 1981-11, Vol.24 (11), p.1284-1287</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a294t-2cc8e03d9d65eb8d4a1c4ff3b51fd8f853cc1437431f023e502baef72f3edb433</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00143a004$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00143a004$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6273558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rogers, Michael E</creatorcontrib><creatorcontrib>Glennon, Richard A</creatorcontrib><creatorcontrib>Smith, J. Doyle</creatorcontrib><creatorcontrib>Boots, Marvin R</creatorcontrib><creatorcontrib>Nanavati, Nitin</creatorcontrib><creatorcontrib>Maconaughey, Julie E</creatorcontrib><creatorcontrib>Aub, Debbie</creatorcontrib><creatorcontrib>Thomas, Sheree</creatorcontrib><creatorcontrib>Bass, R. G</creatorcontrib><creatorcontrib>Mbagwu, Godwin</creatorcontrib><title>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - antagonists &amp; inhibitors</subject><subject>Chemical Phenomena</subject><subject>Chemistry</subject><subject>Purinones - chemical synthesis</subject><subject>Purinones - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtrGzEQxkVJSdykp54DOiWHsu3osQ_3FkJexW4Mds9Cq5USuburjcYb6v8-Mjahhx6Ggfl-fDPzEfKFwTcGnH1fdwBMCg0gP5AJyzlksgJ5RCYAnGe84OKEfEJcA4BgXByT44KXIs-rCWnnFoMPvTd0GKPvQ2-p7nUbnpBqpL5_9rXfhIg0OGq2pvUmu5ov6PAcMFXjLW5s1Gh_UBO6QUePod-xaF_TvKXJ84niNlEdnpGPTrdoPx_6Kfl9e7O6vs9mj3cP11ezTPOp3GTcmMqCaKZNkdu6aqRmRjon6py5pnJVLoxJ_5ZSMAdc2Bx4ra0ruRO2qaUQp-Ri7zvE8DKmC1Xn0di21b0NI6pSlHkxrYoEft2DJgbEaJ0aou903CoGapet-ifbRJ8fbMe6s807ewgz6dle9-nbv--yjn9UsVupVoul4nfL1c_7XzM1T_zlntcG1TqMMeWO_938BijwkkA</recordid><startdate>198111</startdate><enddate>198111</enddate><creator>Rogers, Michael E</creator><creator>Glennon, Richard A</creator><creator>Smith, J. Doyle</creator><creator>Boots, Marvin R</creator><creator>Nanavati, Nitin</creator><creator>Maconaughey, Julie E</creator><creator>Aub, Debbie</creator><creator>Thomas, Sheree</creator><creator>Bass, R. G</creator><creator>Mbagwu, Godwin</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198111</creationdate><title>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</title><author>Rogers, Michael E ; Glennon, Richard A ; Smith, J. Doyle ; Boots, Marvin R ; Nanavati, Nitin ; Maconaughey, Julie E ; Aub, Debbie ; Thomas, Sheree ; Bass, R. G ; Mbagwu, Godwin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a294t-2cc8e03d9d65eb8d4a1c4ff3b51fd8f853cc1437431f023e502baef72f3edb433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - antagonists &amp; inhibitors</topic><topic>Chemical Phenomena</topic><topic>Chemistry</topic><topic>Purinones - chemical synthesis</topic><topic>Purinones - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rogers, Michael E</creatorcontrib><creatorcontrib>Glennon, Richard A</creatorcontrib><creatorcontrib>Smith, J. Doyle</creatorcontrib><creatorcontrib>Boots, Marvin R</creatorcontrib><creatorcontrib>Nanavati, Nitin</creatorcontrib><creatorcontrib>Maconaughey, Julie E</creatorcontrib><creatorcontrib>Aub, Debbie</creatorcontrib><creatorcontrib>Thomas, Sheree</creatorcontrib><creatorcontrib>Bass, R. G</creatorcontrib><creatorcontrib>Mbagwu, Godwin</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rogers, Michael E</au><au>Glennon, Richard A</au><au>Smith, J. Doyle</au><au>Boots, Marvin R</au><au>Nanavati, Nitin</au><au>Maconaughey, Julie E</au><au>Aub, Debbie</au><au>Thomas, Sheree</au><au>Bass, R. G</au><au>Mbagwu, Godwin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1981-11</date><risdate>1981</risdate><volume>24</volume><issue>11</issue><spage>1284</spage><epage>1287</epage><pages>1284-1287</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Several simple alkyl and aralkyl derivatives of mesoionic thiazolopyrimidines (1) and mesoionic 1,3,4-thiadiazolopyrimidines (2) were found to possess theophylline-like activity as inhibitors of cyclic-AMP phosphodiesterase (PDE). Reduction of the C2-C3 double bond of 1 or replacement of the sulfur atom of 1 or 2 with an N-methyl group nearly abolishes activity. Optimal activity appears to be associated with a hydrophobic substituent at the N8 position. The five-membered ring of 1 can be replaced by a pyridine or isoquinoline nucleus without untoward effects. Preliminary kinetic data suggest that the type of enzyme inhibition produced by the mesoionic derivatives is similar to that observed for theophylline. Thus, several novel mesoionic ring systems display activity as inhibitors of cyclic-AMP PDE and can serve as lead compounds for further investigation.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>6273558</pmid><doi>10.1021/jm00143a004</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1981-11, Vol.24 (11), p.1284-1287
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_73756986
source MEDLINE; American Chemical Society Journals
subjects 3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors
Chemical Phenomena
Chemistry
Purinones - chemical synthesis
Purinones - pharmacology
title Mesoionic purinone analogs as inhibitors of cyclic-AMP phosphodiesterase: comparison of several ring systems
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A53%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesoionic%20purinone%20analogs%20as%20inhibitors%20of%20cyclic-AMP%20phosphodiesterase:%20comparison%20of%20several%20ring%20systems&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Rogers,%20Michael%20E&rft.date=1981-11&rft.volume=24&rft.issue=11&rft.spage=1284&rft.epage=1287&rft.pages=1284-1287&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm00143a004&rft_dat=%3Cproquest_cross%3E73756986%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73756986&rft_id=info:pmid/6273558&rfr_iscdi=true